Copyright
©2014 Baishideng Publishing Group Inc.
World J Methodol. Jun 26, 2014; 4(2): 46-58
Published online Jun 26, 2014. doi: 10.5662/wjm.v4.i2.46
Published online Jun 26, 2014. doi: 10.5662/wjm.v4.i2.46
Ref. | Correlation | Direction of correlation | P | |
Physiological parameter | DCE-MRI measurement | |||
Buadu et al[76], 1996 | MVD | Amplitude | + | < 0.01 |
Slope maximum | + | < 0.01 | ||
Enhancement Maximum time | - | < 0.01 | ||
Tumor size | .. | NS | ||
Stomper et al[77], 1996 | DNA S-phase percentage | Signal enhancement amplitude | .. | NS |
Signal enhancement rate | .. | NS | ||
Signal washout | .. | NS | ||
Hulka et al[78], 1997 | Tumor grade | RSI | + | < 0.01 |
Matsubayashi et al[79], 2000 | Peripheral-central MVD ratio | Early rim enhancement | + | 0.048 |
Peripheral-central fibrosis ratio | Early rim enhancement | - | < 0.01 | |
Central-peripheral fibrosis ratio | Delayed rim | + | 0.013 | |
Gianfelice et al[80], 2003 | Residue tumor percentage after MRIgFUS | ISI | + | NR |
MDF | + | NR | ||
PEI | + | NR | ||
Su et al[81], 2003 | VEGF | Apparent Vb | .. | NS |
In-flux rate and distribution volume in interstitial space (VeK1) | .. | NS | ||
Out-flux rate (K2) | .. | NS |
- Citation: Wang CH, Yin FF, Horton J, Chang Z. Review of treatment assessment using DCE-MRI in breast cancer radiation therapy. World J Methodol 2014; 4(2): 46-58
- URL: https://www.wjgnet.com/2222-0682/full/v4/i2/46.htm
- DOI: https://dx.doi.org/10.5662/wjm.v4.i2.46